Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The Stability of Individual Well-Being in Short Windows of Time: Women's Perceptions across the Ovulatory Cycle.

Villani D, Iannello P, Cipresso P, Antonietti A.

Front Psychol. 2017 Nov 30;8:2092. doi: 10.3389/fpsyg.2017.02092. eCollection 2017.

2.

Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.

Eisenlohr-Moul TA, Girdler SS, Johnson JL, Schmidt PJ, Rubinow DR.

Depress Anxiety. 2017 Oct;34(10):908-917. doi: 10.1002/da.22673. Epub 2017 Jul 17.

PMID:
28715852
3.

The influence of early life sexual abuse on oxytocin concentrations and premenstrual symptomatology in women with a menstrually related mood disorder.

Crowley SK, Pedersen CA, Leserman J, Girdler SS.

Biol Psychol. 2015 Jul;109:1-9. doi: 10.1016/j.biopsycho.2015.04.003. Epub 2015 Apr 17.

4.

Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.

Eisenlohr-Moul TA, DeWall CN, Girdler SS, Segerstrom SC.

Biol Psychol. 2015 Jul;109:37-52. doi: 10.1016/j.biopsycho.2015.03.016. Epub 2015 Mar 30.

5.

The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge.

Nillni YI, Rohan KJ, Zvolensky MJ.

Arch Womens Ment Health. 2012 Dec;15(6):413-22. doi: 10.1007/s00737-012-0302-2. Epub 2012 Aug 25.

6.

Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA.

Am J Psychiatry. 2012 May;169(5):465-75.

7.

Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction.

Nillni YI, Toufexis DJ, Rohan KJ.

Clin Psychol Rev. 2011 Nov;31(7):1183-91. doi: 10.1016/j.cpr.2011.07.006. Epub 2011 Jul 26. Review.

8.

Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.

Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O'Malley SS.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):1-8. doi: 10.1016/j.drugalcdep.2010.04.021. Epub 2010 Jun 19.

9.

Update on research and treatment of premenstrual dysphoric disorder.

Cunningham J, Yonkers KA, O'Brien S, Eriksson E.

Harv Rev Psychiatry. 2009;17(2):120-37. doi: 10.1080/10673220902891836. Review.

10.

Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.

Potter J, Bouyer J, Trussell J, Moreau C.

J Womens Health (Larchmt). 2009 Jan-Feb;18(1):31-9. doi: 10.1089/jwh.2008.0932.

11.

Premenstrual dysphoric disorder: burden of illness and treatment update.

Pearlstein T, Steiner M.

J Psychiatry Neurosci. 2008 Jul;33(4):291-301.

12.

Premenstrual syndrome.

Yonkers KA, O'Brien PM, Eriksson E.

Lancet. 2008 Apr 5;371(9619):1200-10. doi: 10.1016/S0140-6736(08)60527-9.

13.
14.

Premenstrual Dysphoric Disorder: Recognition and Treatment.

Freeman EW, Sondheimer SJ.

Prim Care Companion J Clin Psychiatry. 2003 Feb;5(1):30-39.

Supplemental Content

Support Center